Achalasia: a new clinically relevant classification by high-resolution manometry

John E Pandolfino, Monika A Kwiatek, Thomas Nealis, William Bulsiewicz, Jennifer Post, Peter J Kahrilas, John E Pandolfino, Monika A Kwiatek, Thomas Nealis, William Bulsiewicz, Jennifer Post, Peter J Kahrilas

Abstract

Background & aims: Although the diagnosis of achalasia hinges on demonstrating impaired esophagogastric junction (EGJ) relaxation and aperistalsis, 3 distinct patterns of aperistalsis are discernable with high-resolution manometry (HRM). This study aimed to compare the clinical characteristics and treatment response of these 3 subtypes.

Methods: One thousand clinical HRM studies were reviewed, and 213 patients with impaired EGJ relaxation were identified. These were categorized into 4 groups: achalasia with minimal esophageal pressurization (type I, classic), achalasia with esophageal compression (type II), achalasia with spasm (type III), and functional obstruction with some preserved peristalsis. Clinical and manometric variables including treatment response were compared among the 3 achalasia subtypes. Logistic regression analysis was performed using treatment success as the dichotomous dependent variable controlling for independent manometric and clinical variables.

Results: Ninety-nine patients were newly diagnosed with achalasia (21 type I, 49 type II, 29 type III), and 83 of these had sufficient follow-up to analyze treatment response. Type II patients were significantly more likely to respond to any therapy (BoTox [71%], pneumatic dilation [91%], or Heller myotomy [100%]) than type I (56% overall) or type III (29% overall) patients. Logistic regression analysis found type II to be a predictor of positive treatment response, whereas type III and pretreatment esophageal dilatation were predictive of negative treatment response.

Conclusions: Achalasia can be categorized into 3 subtypes that are distinct in terms of their responsiveness to medical or surgical therapies. Utilizing these subclassifications would likely strengthen future prospective studies of treatment efficacy in achalasia.

Conflict of interest statement

Conflict of interests: John Pandolfino (consultant: Astra Zeneca, Santarus, Medtronic, Crospon, TAP; speaker: Astra Zeneca, Santarus, Medtronic); Monika Kwiatek (none), Thomas Nealis (none), William Bulsiewicz (none), Jennifer Post (none), and Peter J. Kahrilas (none). Other conflicts of interest were not disclosed because this was a retrospective analysis of medical records and manometry studies.

Figures

Figure 1
Figure 1
Methodology for using the isobaric contour tool to determine the 4-second IRP and the PFV. The pressure highlighted by the isobaric contour tool is progressively increased during analysis until it excludes a period of 4 seconds from the pressure domain of the EGJ. That value is equal to the 4-second IRP and, in this example, is equal to 10 mm Hg because the 3 segments (white bars) define a cumulative period of time of 4 seconds during which the pressure is less than 10 mm Hg (solid isobaric line). The PFV is illustrated using a second isobaric contour with a setting of 30 mm Hg (dashed black line). The PFV is the slope of the line connecting the distal temporal margin of the transition zone with the superior proximal margin of the EGJ on the 30-mm Hg isobaric contour line (pink dashed line), expressed in centimeters/seconds. In this example, the PFV is 3.5 cm/s.
Figure 2
Figure 2
Achalasia subtypes. The subtypes are distinguished by 3 distinct manometric patterns of esophageal body contractility. Type I is illustrated in both a color pressure topography plot (A) and as a 3-dimensional plot to illustrate the pressure gradients spanning the esophagus and proximal stomach (B). In panel a, there is no significant pressurization within the body of the esophagus, and this would be classified as failed peristalsis with an IRP of 42 mm Hg. The 3-dimensional rendering of these pressure data in B clearly illustrates that esophagogastric flow cannot occur because the esophageal pressure is too low to overcome the EGJ high-pressure zone. C represents a swallow from a type II achalasia patient with compartmentalized pressurization spanning the entire length of the esophagus. The 3-dimensional rendering of these pressure data (D) illustrates that the isobaric column within the esophagus equals the EGJ pressure and would likely be associated with esophagogastric flow. E illustrates a pressure topography plot of a spastic contraction in a type III achalasia patient. Although this swallow is also associated with rapidly propagated pressurization, the pressurization is attributable to an abnormal lumen obliterating contraction. The 3-dimensional rendering of these pressure data (F) illustrates the peaks and valleys of that spastic contraction, and this swallow would likely appear as a rosary-bead pattern on fluoroscopy.
Figure 3
Figure 3
Flow chart of the patient population analyzed.
Figure 4
Figure 4
Maximal esophageal pressurization in the distal esophagus during the 10 test swallows among achalasia subtypes. Values plotted are the means for each patient at whatever locus along the distal segment exhibited the greatest pressure. Type II patients exhibited significantly greater pressures than type I, whereas type III patient pressures were greater than types I or II.

References

    1. Spechler SJ, Castell DO. Classification of oesophageal motility abnormalities. Gut. 2001;49:145–151.
    1. Pandolfino JE, Kahrilas PJ. AGA technical review on the clinical use of esophageal manometry. Gastroenterology. 2005;128:209–224.
    1. Goldenberg SP, Burrell M, Fette GG, et al. Classic and vigorous achalasia: a comparison of manometric, radiographic, and clinical findings. Gastroenterology. 1991;101:743–748.
    1. Todorczuk JR, Aliperti G, Staiano A, et al. Reevaluation of manometric criteria for vigorous achalasia. Is this a distinct clinical disorder? Dig Dis Sci. 1991;36:274–278.
    1. Hirano I, Tatum RP, Shi G, et al. Manometric heterogeneity in patients with idiopathic achalasia. Gastroenterology. 2001;120:789–798.
    1. Csendes A, Braghetto I, Henriquez A, et al. Late results of a prospective randomised study comparing forceful dilatation and oesophagomyotomy in patients with achalasia. Gut. 1989;30:299–304.
    1. Pasricha PJ, Rai R, Ravich WJ, et al. Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology. 1996;110:1410–1415.
    1. Vaezi MF, Richter JE, Wilcox CM, et al. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut. 1999;44:231–239.
    1. Annese V, Bassotti G, Coccia G, et al. A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group. Gut. 2000;46:597–600.
    1. Mikaeli J, Fazel A, Montazeri G, et al. Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia. Aliment Pharmacol Ther. 2001;15:1389–1396.
    1. Bansal R, Nostrant TT, Scheiman JM, et al. Intrasphincteric botulinum toxin versus pneumatic balloon dilation for treatment of primary achalasia. J Clin Gastroenterol. 2003;36:209–214.
    1. Bonatti H, Hinder RA, Klocker J, et al. Long-term results of laparoscopic Heller myotomy with partial fundoplication for the treatment of achalasia. Am J Surg. 2005;190:874–878.
    1. Vela MF, Richter JE, Khandwala F, et al. The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol. 2006;4:580–587.
    1. Gockel I, Junginger T, Eckardt VF. Long-term results of conventional myotomy in patients with achalasia: a prospective 20-year analysis. J Gastrointest Surg. 2006;10:1400–1408.
    1. Sanderson DR, Ellis FH, Jr, Schlegel JF, et al. Syndrome of vigorous achalasia: clinical and physiologic observations. Dis Chest. 1967;52:508–517.
    1. Bondi JL, Godwin DH, Garrett JM. “Vigorous” achalasia. Its clinical interpretation and significance. Am J Gastroenterol. 1972;58:145–155.
    1. Camacho-Lobato L, Katz PO, Eveland J, et al. Vigorous achalasia: original description requires minor change. J Clin Gastroenterol. 2001;33:375–377.
    1. Fox M, Hebbard G, Janiak P, et al. High-resolution manometry predicts the success of oesophageal bolus transport and identifies clinically important abnormalities not detected by conventional manometry. Neurogastroenterol Motil. 2004;16:533–542.
    1. Pandolfino JE, Ghosh SK, Rice J, et al. Classifying esophageal motility by pressure topography characteristics: a study of 400 patients and 75 controls. Am J Gastroenterol. 2008;103:27–37.
    1. Ghosh SK, Pandolfino JE, Rice J, et al. Impaired deglutitive EGJ relaxation in clinical esophageal manometry: a quantitative analysis of 400 patients and 75 controls. Am J Physiol Gastrointest Liver Physiol. 2007;293:G878–G885.
    1. Pandolfino JE, Ghosh SK, Zhang Q, et al. Quantifying EGJ morphology and relaxation with high-resolution manometry: a study of 75 asymptomatic volunteers. Am J Physiol Gastrointest Liver Physiol. 2006;290:G1033–1040.
    1. Staiano A, Clouse RE. Detection of incomplete lower esophageal sphincter relaxation with conventional point-pressure sensors. Am J Gastroenterol. 2001;96:3258–3267.

Source: PubMed

3
Iratkozz fel